IOVA
Price
$3.54
Change
+$0.29 (+8.92%)
Updated
Apr 2 closing price
Capitalization
1.16B
40 days until earnings call
RCKT
Price
$6.30
Change
+$0.49 (+8.43%)
Updated
Apr 2 closing price
Capitalization
671.77M
39 days until earnings call
Ad is loading...

IOVA vs RCKT

Header iconIOVA vs RCKT Comparison
Open Charts IOVA vs RCKTBanner chart's image
Iovance Biotherapeutics
Price$3.54
Change+$0.29 (+8.92%)
Volume$7.53M
Capitalization1.16B
Rocket Pharmaceuticals
Price$6.30
Change+$0.49 (+8.43%)
Volume$4.52M
Capitalization671.77M
IOVA vs RCKT Comparison Chart
Loading...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOVA vs. RCKT commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Buy and RCKT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IOVA: $3.54 vs. RCKT: $5.81)
Brand notoriety: IOVA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOVA: 78% vs. RCKT: 459%
Market capitalization -- IOVA: $1.16B vs. RCKT: $671.77M
IOVA [@Biotechnology] is valued at $1.16B. RCKT’s [@Biotechnology] market capitalization is $671.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOVA’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • IOVA’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both IOVA and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOVA’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • IOVA’s TA Score: 5 bullish, 3 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than RCKT.

Price Growth

IOVA (@Biotechnology) experienced а +2.91% price change this week, while RCKT (@Biotechnology) price change was -28.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

IOVA is expected to report earnings on May 13, 2025.

RCKT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($1.16B) has a higher market cap than RCKT($672M). RCKT (-49.881) and IOVA (-52.162) have similar YTD gains . RCKT has higher annual earnings (EBITDA): -247.48M vs. IOVA (-351.67M). RCKT has more cash in the bank: 372M vs. IOVA (324M). RCKT has less debt than IOVA: RCKT (25.5M) vs IOVA (58.3M). IOVA has higher revenues than RCKT: IOVA (164M) vs RCKT (0).
IOVARCKTIOVA / RCKT
Capitalization1.16B672M173%
EBITDA-351.67M-247.48M142%
Gain YTD-52.162-49.881105%
P/E RatioN/AN/A-
Revenue164M0-
Total Cash324M372M87%
Total Debt58.3M25.5M229%
FUNDAMENTALS RATINGS
IOVA vs RCKT: Fundamental Ratings
IOVA
RCKT
OUTLOOK RATING
1..100
544
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
9595
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (30) in the Biotechnology industry is in the same range as IOVA (38). This means that RCKT’s stock grew similarly to IOVA’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IOVA (100). This means that RCKT’s stock grew similarly to IOVA’s over the last 12 months.

RCKT's SMR Rating (97) in the Biotechnology industry is in the same range as IOVA (98). This means that RCKT’s stock grew similarly to IOVA’s over the last 12 months.

RCKT's Price Growth Rating (95) in the Biotechnology industry is in the same range as IOVA (95). This means that RCKT’s stock grew similarly to IOVA’s over the last 12 months.

RCKT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IOVA (100). This means that RCKT’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IOVARCKT
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGLRX16.120.10
+0.62%
MFS Global Real Estate R6
TAMVX30.79N/A
N/A
T. Rowe Price Mid-Cap Value Adv
GARJX9.53N/A
N/A
Goldman Sachs Global Rl Estt Secs Inv
HGXCX14.87N/A
N/A
Hartford Global Impact C
FNGRX15.60N/A
N/A
Franklin Intl Growth R

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with ALDX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
+8.92%
ALDX - IOVA
47%
Loosely correlated
-2.74%
CRSP - IOVA
47%
Loosely correlated
+3.17%
RCKT - IOVA
44%
Loosely correlated
+8.43%
VCYT - IOVA
43%
Loosely correlated
+1.93%
DNLI - IOVA
43%
Loosely correlated
+11.80%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+8.43%
DNLI - RCKT
56%
Loosely correlated
+11.80%
NTLA - RCKT
56%
Loosely correlated
+9.69%
RGNX - RCKT
54%
Loosely correlated
+4.29%
AXON - RCKT
52%
Loosely correlated
+3.18%
CRSP - RCKT
51%
Loosely correlated
+3.17%
More